B

bluebird bio
D

BLUE

4.10000
USD
-2.93
(-41.68%)
مغلق
حجم التداول
141,149
الربح لكل سهم
-16
العائد الربحي
-
P/E
-0
حجم السوق
39,861,090
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: bluebird bio Inc

القطاع: Healthcare
الصناعة: Biotechnology
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.